Problem: Pharmaceutical CROs face rising costs and intense competition, making efficiency and speed critical. Delays occur in feasibility reports, protocol creation, study execution, and report submission due to CRD overload, poor training, and unsynchronised workflows. This leads to regulatory queries, missed deadlines, and dissatisfied clients. Solution: A structured approach was implemented to decouple CRD from conflicting tasks, introduce WIP control, synchronize workflows, improve training, and enhance study visibility with project management tools. Benefits: These changes reduced study observations by 40%-50%, improved turnaround by 25%-35%, enhanced regulatory compliance, and strengthened CRO-client partnerships, boosting reputation and business growth.

Key Takeaways

How can Indian CROs reduce the number of observations and deviations observed during the studies by 40%-50% and generate the final integrated report 25%-35% faster with the same resources while protecting the quality of reports? Find out

Agile CROs can fly high

Problem: Pharmaceutical CROs face rising costs and intense competition, making efficiency and speed critical. Delays occur in feasibility reports, protocol creation, study execution, and report submission due to CRD overload, poor training, and unsynchronised workflows. This leads to regulatory queries, missed deadlines, and dissatisfied clients. Solution: A structured approach was implemented to decouple CRD from conflicting tasks, introduce WIP control, synchronize workflows, improve training, and enhance study visibility with project management tools. Benefits: These changes reduced study observations by 40%-50%, improved turnaround by 25%-35%, enhanced regulatory compliance, and strengthened CRO-client partnerships, boosting reputation and business growth.

Download PDF

Explore how Agile CROs are reshaping pharmaceutical clinical trials with speed, quality, and cost-effectiveness, amid rising global demands and regulatory challenges.

Let's Empower Growth